Study of <italic>Dahuang-Huanglian-Xiexin</italic> decoction combined with conventional western medicine in patients with type 2 diabetes

Jing LI; Haihui Zhu; Yaling Pang; Rui Yang; Dongliang Wang; Yuyuan Wang; Feng Qiao

Return

Study of Dahuang-Huanglian-Xiexin decoction combined with conventional western medicine in patients with type 2 diabetes

VernacularTitle: 大黄黄连泻心汤结合西医常规疗法治疗2型糖尿病临床研究
Author: Jing LI ¹ ; Haihui ZHU ² ; Yaling PANG ³ ; Rui YANG ² ; Dongliang WANG ¹ ; Yuyuan WANG ¹ ; Feng QIAO ⁴
Author Information

1. Department of Traditional Chinese Medicine, Shaanxi People's Hospital, Xi'an 710068, China
2. Department of Endocrine, Shaanxi Traditional Chinese Medicine Hospital, Xi'an 710003, China
3. Department of Endocrinology, Shaanxi People's Hospital, Xi'an 710068, China
4. Chinese Medicine Internal Medicine, Yulin Traditional Chinese Medicine Hospital, Yulin 719000, China
Publication Type:Clinical Trail
Keywords: Diabetes mellitus, type 2; Lipid metabolism disorders; Intestinal microflora; Dahuang-Huanglian-Xiexin decoction; Therapies, investigational
From: International Journal of Traditional Chinese Medicine 2019;41(12):1301-1305
CountryChina
Language:Chinese
Abstract: Objective:To evaluate the effects of the classical prescriptions Dahuang-Huanglian-Xiexin decoction combined with conventional western medicine on the lipid metabolism disorder and changes of intestinal microflora in patients with type 2 diabetes mellitus (T2DM).
Methods:A total of 120 patients who met the inclusion criteria were divided into the two group according to the treatment order, with 60 patients in each group. Both groups were given conventional hypoglycemic therapy, the control group was given bifidobacteria lactobacillus triple viable tablets, and the treatment group was given Dahuang-Huanglian-Xiexin decoction on the basis of the control group. Both groups were treated with 14 days for one course and 4 courses in total. The number of gram-positive coccus (G+c), gram-negative coccus (G-c), gram-positive bacillus (G+b) and gram-negative bacillus (G-b) in each 500 bacteria were observed under oil microscope, and the cocci/bacillus ratio were calculated. The TC and TG were detected by oxidase method, and HDL and LDL were detected by automatic biochemical analyzer. The FPG, 2 hPG and HbA1c were detected by automatic biochemical analyzer. TCM symptom scores were calculated.
Results:After treatment, the abdominal distension, congestion discomfort, and constipation score were significantly lower than the control group (t values were 3.685, 3.551 and 3.708, respectively, all Ps<0.05); Serum TG, TC and LDL-c levels were significantly lower than the control group (t values were 3.602, 3.581 and 3.421, respectively, all Ps<0.05); HDL-c level was significantly higher than that of the control group (t=3.358, P=0.046); Serum FPG, 2 hPG and HbA1c levels were significantly lower than the control group (t values were 3.502, 3.271 and 3.708, respectively, all Ps<0.05). After treatment, the G-c (271.47/500 ± 22.63/500 vs. 266.81/500 ± 22.36/500, t=3.792), G+b (81.26/500 ± 6.52/500 vs. 73.19/500 ± 6.94/500, t=3.511), G-b (183.76/500 ± 16.19/500 vs. 164.37/500 ± 15.83/500, t=3.306) levels in the treatment group significantly higher than those in the control group (P<0.05). After treatment, both c/b levels was (0.65 ± 0.13 vs. 0.87 ± 0.21, t=3.325) decreased significantly (P<0.05).
Conclusions:Dahuang-Huanglian-Xiexin decoction combined with conventional western medicine can improve the clinical symptoms of T2DM patients, reduce blood glucose and lipid levels, and inhibit the body mass and improve insulin resistance by adjusting the structure of intestinal flora, increasing probiotics and reducing pathogenic bacteria.